(Q85937415)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes : a population approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

1 reference

A Gaudard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

E Varlet-Marie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M Audran

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

R Gomeni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

F Bressolle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

167-179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

The molecular mechanism of erythropoietin action

22 February 2020

cites work

1 reference

12 December 2020

The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects

1 reference

12 December 2020

Strategies for iron supplementation: oral versus intravenous

1 reference

12 December 2020

Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control

1 reference

12 December 2020

Diurnal variation of serum immunomoreactive erythropoietin in a normal subject

1 reference

12 December 2020

Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes.

1 reference

12 December 2020

Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise

1 reference

12 December 2020

Reticulocyte hemoglobin: an integrated parameter for evaluation of erythropoietic activity

1 reference

12 December 2020

Pharmacokinetics/Pharmacodynamics of Recombinant Human Erythropoietins in Doping Control1

1 reference

12 December 2020

Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men.

1 reference

12 December 2020

Transferrin soluble receptor: a possible probe for detection of erythropoietin abuse by athletes

1 reference

12 December 2020

Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous production

1 reference

12 December 2020

Comparison of a direct and indirect population pharmacodynamic model: application to recombinant human erythropoietin in athletes.

1 reference

12 December 2020

Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers

1 reference

12 December 2020

The future of doping control in athletes. Issues related to blood sampling

1 reference

12 December 2020

Effect of rhEPO administration on serum levels of sTfR and cycling performance

1 reference

12 December 2020

Reticulocyte Parameters as Potential Discriminators of Recombinant Human Erythropoietin Abuse in Elite Athletes

1 reference

12 December 2020

The second international reference preparation of erythropoietin, human, urinary, for bioassay

1 reference

12 December 2020

The metabolism of erythropoietin in liver cirrhosis patients compared with healthy volunteers

1 reference

12 December 2020

Hematological Indices of Erythropoietin Administration in Athletes

1 reference

12 December 2020

Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis

1 reference

12 December 2020

Evaluation of the stability of human erythropoietin in samples for radioimmunoassay

1 reference

12 December 2020

Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis

1 reference

12 December 2020

Recombinant erythropoietin in urine

1 reference

12 December 2020

Double-blotting: a solution to the problem of non-specific binding of secondary antibodies in immunoblotting procedures

1 reference

12 December 2020

Effects of erythropoietin administration in training athletes and possible indirect detection in doping control

1 reference

12 December 2020

A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes

1 reference

12 December 2020

Diurnal levels of immunoreactive erythropoietin in normal subjects and subjects with chronic lung disease

1 reference

12 December 2020

Use of recombinant human erythropoietin as an antianemic and performance enhancing drug

1 reference

12 December 2020

Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software

1 reference

12 December 2020

10.2165/00044011-200323030-00003

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340923%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference